3 Recession-Ready Stocks to Buy in November
If you're worried about a recession, you might want to consider these top picks.
If You Invested $500 in Boeing's IPO, This Is How Much Money You'd Have Now
Buy-and-hold investors who got into Boeing early have done very well over the years.
3 Stocks the World's Best Investors Are Buying Right Now
Top investors oversee billions' worth of assets for a reason, so why not check out what they are buying?
Did FCA bribe union leaders to hurt GM?
For investors hoping to take a profitable bite out of the plant-based burger market, the biggest meat producer in the U.S. may be a strong play.
The maritime leasing company reported solid charter hire activity, but vessel impairments impacted its bottom line.
History is littered with promising phase 2 drugs that failed upon further testing. Investors shouldn't get caught up in the hype.
The gene-editing pioneer announced the pricing of a public stock offering.
Intel apologized to its customers, and Exxon is looking to raise $25 billion.
The struggling retailer falls into the classic trap of using markdowns to boost sales.
The landmark legislation could pave the way for weed to become legal at the federal level.
A big acquisition is helping results for Berry Global.
The RealReal's shares sank after a report highlighting possible flaws in the process it uses to authenticate the luxury goods sold on its website, but management's reaction may be an opportunity to win investor confidence.
Amid reports of eased restrictions on foreign ownership, investors would do well to take a closer look at the Russian Internet search leader's latest results.
Two factors contributed to strong top- and bottom-line growth.
Last week, Weight Watchers International rolled out myWW, offering members a customized approach to weight management. But will its new program and its rebranding effort help it recover from slimmer third-quarter revenue results?
Strong growth and narrowing losses sent the software stock higher.
There are a couple of reasons L Brands might have jumped today in spite of its lackluster third-quarter results.
Growth accelerated during the third quarter, but not by as much as management had predicted.
Slowing sales cloud the fiscal 2019 picture as the organization heads into the fourth quarter.
A secondary offering resets the valuation of the ear, nose, and throat specialist.
Why Marijuana Stocks Aurora Cannabis, Canopy Growth, Cronos Group, HEXO, and OrganiGram Are Crushing It Today
A huge milestone toward legalizing marijuana in the U.S. is providing a big catalyst for Canadian marijuana stocks.
Insider investors appear to be abandoning ship.